Quest Diagnostics (NYSE:DGX) just reported results for the first quarter of 2024.
- Quest Diagnostics reported earnings per share of $2.04. This was above the analyst estimate for EPS of $1.85.
- The company reported revenue of $2.37 billion.
- This was 3.32% better than the analyst estimate for revenue of $2.29 billion.